Literature DB >> 25229251

Toll-like receptor 3 increases allergic and irritant contact dermatitis.

Naomi Nakamura1, Risa Tamagawa-Mineoka2, Mayumi Ueta3, Shigeru Kinoshita3, Norito Katoh1.   

Abstract

There is increasing recognition of the role of Toll-like receptor 3 (TLR3) in noninfectious inflammatory diseases, but the function of TLR3 in inflammatory skin diseases is unclear. We investigated the functions of TLR3 in allergic and irritant contact dermatitis (ICD). The contact hypersensitivity (CHS) response was lower in Toll-like receptor 3 knockout (Tlr3 KO) mice, and was greater in TLR3 transgenic (Tg) mice than in wild-type (WT) mice after challenge with 2,4,6-trinitro-1-chlorobenzene. Adoptive transfer of immunized lymph node cells from Tlr3 KO mice induced CHS in WT recipients. In contrast, adoptive transfer of those from WT mice did not fully induce CHS in Tlr3 KO recipients. The ICD reaction following croton oil application was lower in Tlr3 KO mice, and was greater in TLR3 Tg mice than in WT mice. Maturation, migration, and antigen presentation of dendritic cells and proliferation of lymphocytes between WT mice and Tlr3 KO mice were comparable. These results show that TLR3 enhances antigen-independent skin inflammation in the elicitation phase of allergic contact dermatitis and in ICD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25229251     DOI: 10.1038/jid.2014.402

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  44 in total

1.  Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses.

Authors:  Seung-Yong Seong; Polly Matzinger
Journal:  Nat Rev Immunol       Date:  2004-06       Impact factor: 53.106

2.  Ultraviolet radiation damages self noncoding RNA and is detected by TLR3.

Authors:  Jamie J Bernard; Christopher Cowing-Zitron; Teruaki Nakatsuji; Beda Muehleisen; Jun Muto; Andrew W Borkowski; Laisel Martinez; Eric L Greidinger; Benjamin D Yu; Richard L Gallo
Journal:  Nat Med       Date:  2012-07-08       Impact factor: 53.440

3.  Toll-like receptor 3 enhances late-phase reaction of experimental allergic conjunctivitis.

Authors:  Mayumi Ueta; Satoshi Uematsu; Shizuo Akira; Shigeru Kinoshita
Journal:  J Allergy Clin Immunol       Date:  2009-04-10       Impact factor: 10.793

4.  Hyaluronan fragments act as an endogenous danger signal by engaging TLR2.

Authors:  Kara A Scheibner; Michael A Lutz; Sada Boodoo; Matthew J Fenton; Jonathan D Powell; Maureen R Horton
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

Review 5.  Toll-like receptors and their crosstalk with other innate receptors in infection and immunity.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Immunity       Date:  2011-05-27       Impact factor: 31.745

6.  Toll-like receptor 3 L412F polymorphisms in infants with bronchiolitis and postbronchiolitis wheezing.

Authors:  Kirsi Nuolivirta; Qiushui He; Juho Vuononvirta; Petri Koponen; Merja Helminen; Matti Korppi
Journal:  Pediatr Infect Dis J       Date:  2012-09       Impact factor: 2.129

7.  mRNA is an endogenous ligand for Toll-like receptor 3.

Authors:  Katalin Karikó; Houping Ni; John Capodici; Marc Lamphier; Drew Weissman
Journal:  J Biol Chem       Date:  2004-01-16       Impact factor: 5.157

8.  TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells.

Authors:  Atsushi Kato; Silvio Favoreto; Pedro C Avila; Robert P Schleimer
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

9.  Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy.

Authors:  Jan P Tuckermann; Anna Kleiman; Richard Moriggl; Rainer Spanbroek; Anita Neumann; Anett Illing; Björn E Clausen; Brenda Stride; Irmgard Förster; Andreas J R Habenicht; Holger M Reichardt; François Tronche; Wolfgang Schmid; Günther Schütz
Journal:  J Clin Invest       Date:  2007-04-19       Impact factor: 14.808

10.  Therapeutic efficacy and immunological response of CCL5 antagonists in models of contact skin reaction.

Authors:  Miriam Canavese; Fiorella Altruda; Lorenzo Silengo
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

View more
  5 in total

Review 1.  Recent advances in understanding and managing contact dermatitis.

Authors:  Stefan F Martin; Thomas Rustemeyer; Jacob P Thyssen
Journal:  F1000Res       Date:  2018-06-20

2.  Difference in the plasma level of miR-628-3p in atopic dermatitis patients with/without atopic keratoconjunctivitis.

Authors:  Mayumi Ueta; Hiromi Nishigaki; Seitaro Komai; Chie Sotozono; Shigeru Kinoshita
Journal:  Immun Inflamm Dis       Date:  2021-09-21

Review 3.  Susceptibility Genes and HLA for Cold Medicine-Related SJS/TEN with SOC.

Authors:  Mayumi Ueta
Journal:  Front Genet       Date:  2022-07-11       Impact factor: 4.772

Review 4.  Atopic Dermatitis: Identification and Management of Complicating Factors.

Authors:  Risa Tamagawa-Mineoka; Norito Katoh
Journal:  Int J Mol Sci       Date:  2020-04-11       Impact factor: 5.923

5.  Differential influence of Streptococcus mitis on host response to metals in reconstructed human skin and oral mucosa.

Authors:  Lin Shang; Dongmei Deng; Sanne Roffel; Susan Gibbs
Journal:  Contact Dermatitis       Date:  2020-08-31       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.